CTX as a Marker for BRONJ

摘要

In the article titled C-Terminal Cross-Linking Telopeptide as a Serologic Marker for Bisphosphonate-Related Osteonecrosis of the Jaw, a condensed version of which was published in print JCDA Issue 4, 2013, the author presents a case report involving the treatment of a patient with multiple myeloma who had previously been treated with intravenous (IV) bisphosphonates.